"Brand New Science" - This Biotech Is Entering Clinical Studies With What It Says Is Novel Science No One Else Has

Greg Gorgas, President & CEO of Artelo Biosciences ARTL, was recently a guest on Benzinga's All-Access.

Artelo is a clinical-stage pharmaceutical company dedicated to the development and commercialization of proprietary therapeutics that modulate lipid-signaling pathways including the endocannabinoid system. 

Artelo has a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, anxiety, pain, neuropathy and inflammation.

Mr. Gorgas spoke about the innovative science that his company is pushing forward. 

Learn more here:

Featured photo by Hal Gatewood on Unsplash.

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.